Fatty acid desaturase gene polymorphisms and metabolic measures in schizophrenia and bipolar patients taking antipsychotics

Cardiovascular Psychiatry and Neurology

Volumn 2013, Issue , 2013, Pages

  Burghardt, Kyle J ^a   Gardner, Kristen N ^b   Johnson, Joshua W ^a   Ellingrod, Vicki L ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNC Hamner Institute for Drug Safety Sciences   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893791503     PISSN: 20900163     EISSN: 20900171     Source Type: Journal    
DOI: 10.1155/2013/596945     Document Type: Article

References (43)

1. Stahl S. M., Morrissette D. A., Citrome L., 'Meta-guidelines' for the management of patients with schizophrenia. CNS Spectrums 2013 18 3 150 162
2. Geddes J. R., Miklowitz D. J., Treatment of bipolar disorder. The Lancet 2013 381 9878 1672 1682
3. Connolly K. R., Thase M. E., The clinical management of bipolar disorder: a review of evidence-based guidelines. Primary Care Companion to the Journal of Clinical Psychiatry 2011 13 4 2-s2.0-80053075213 10.4088/PCC.10r01097
4. Lee S. H., Ripke S., Neale B. M., Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics 2013 45 9 984 994
5. Smoller J. W., Craddock N., Kendler K., Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. The Lancet 2013 381 9875 1371 1379
6. Green E. K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., Gordon-Smith K., Fraser C., Forty L., Russell E., Hamshere M. L., Moskvina V., Nikolov I., Farmer A., McGuffin P., Holmans P. A., O'Donovan M. C., Craddock N., The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Molecular Psychiatry 2010 15 10 1016 1022 2-s2.0-77954510735 10.1038/mp.2009.49
7. Peerbooms O. L. J., van Os J., Drukker M., Kenis G., Hoogveld L., de Hert M., Delespaul P., van Winkel R., Rutten B. P. F., Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? Brain, Behavior, and Immunity 2011 25 8 1530 1543 2-s2.0-80053911645 10.1016/j.bbi.2010.12.006
8. Colton C. W., Manderscheid R. W., Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease 2006 3 2, article A42 2-s2.0-33748885080
9. Fagiolini A., Chengappa K. N. R., Soreca I., Chang J., Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden. CNS Drugs 2008 22 8 655 669 2-s2.0-46749093323 10.2165/00023210- 200822080-00004 (Pubitemid 351950097)
10. Laursen T. M., Munk-Olsen T., Vestergaard M., Life expectancy and cardiovascular mortality in persons with schizophrenia. Current Opinion in Psychiatry 2012 25 2 83 88 2-s2.0-84857056404 10.1097/YCO.0b013e32835035ca
11. Ward A., Quon P., Abouzaid S., Haber N., Ahmed S., Kim E., Cardiometabolic consequences of therapy for chronic schizophrenia using second-generation antipsychotic agents in a medicaid population: clinical and economic evaluation. P and T 2013 38 2 109 115
12. Boden G., Shulman G. I., Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β -cell dysfunction. European Journal of Clinical Investigation 2002 32 supplement 3 14 23 2-s2.0-8844255630 10.1046/j.1365-2362.32.s3.3.x (Pubitemid 41704996)
13. Boden G., Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes 2003 111 3 121 124 2-s2.0-0037643536 10.1055/s-2003-39781 (Pubitemid 36682048)
14. Boden G., Obesity, insulin resistance and free fatty acids. Current Opinion in Endocrinology, Diabetes and Obesity 2011 18 2 139 143 2-s2.0-79952451443 10.1097/MED.0b013e3283444b09
15. Merino D. M., Ma D. W., Genetic variation in lipid desaturases and its impact on the development of human disease. Lipids in Health and Disease 2010 9, article 63 2-s2.0-77953624808 10.1186/1476-511X-9-63
16. Glaser C., Lattka E., Rzehak P., Steer C., Koletzko B., Genetic variation in polyunsaturated fatty acid metabolism and its potential relevance for human development and health. Maternal and Child Nutrition 2011 7 supplement 2 27 40 2-s2.0-79952233101 10.1111/j.1740-8709.2011.00319.x
17. Lattka E., Illig T., Heinrich J., Koletzko B., Do FADS genotypes enhance our knowledge about fatty acid related phenotypes? Clinical Nutrition 2010 29 3 277 287 2-s2.0-77953539296 10.1016/j.clnu.2009.11.005
18. McNamara R. K., Jandacek R., Rider T., Tso P., Hahn C.-G., Richtand N. M., Stanford K. E., Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications. Schizophrenia Research 2007 91 1-3 37 50 2-s2.0-33847314119 10.1016/j.schres.2006.11.027
19. Vik-Mo A. O., Birkenaes A. B., Fernø J., Jonsdottir H., Andreassen O. A., Steen V. M., Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients. International Journal of Neuropsychopharmacology 2008 11 5 679 684 2-s2.0-46449138724 10.1017/S1461145708008468 (Pubitemid 351931824)
20. Liu Y., Jandacek R., Rider T., Tso P., McNamara R. K., Elevated delta-6 desaturase (FADS2) expression in the postmortem prefrontal cortex of schizophrenic patients: relationship with fatty acid composition. Schizophrenia Research 2009 109 1-3 113 120 2-s2.0-62649085037 10.1016/j.schres.2008.12.027
21. McNamara R. K., Jandacek R., Rider T., Tso P., Cole-Strauss A., Lipton J. W., Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: relationship with liver delta6-desaturase expression. Schizophrenia Research 2011 129 1 57 65 2-s2.0-79956143583 10.1016/j.schres. 2011.03.006
22. McNamara R. K., Jandacek R., Rider T., Tso P., Cole-Strauss A., Lipton J. W., Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: relationship with stearoyl-CoA desaturase activity. Schizophrenia Research 2011 129 1 66 73 2-s2.0-79956088603 10.1016/j.schres. 2011.03.016
23. Liu Y., McNamara R. K., Elevated Delta-6 desaturase (FADS2) gene expression in the prefrontal cortex of patients with bipolar disorder. Journal of Psychiatric Research 2011 45 2 269 272 2-s2.0-78650680211 10.1016/j.jpsychires.2010.06.010
24. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
25. Muniyappa R., Lee S., Chen H., Quon M. J., Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. The American Journal of Physiology 2008 294 1 E15 E26 2-s2.0-38349006256 10.1152/ajpendo.00645.2007
26. Rössner S. M., Neovius M., Mattsson A., Marcus C., Norgren S., HOMA-IR and QUICKI: decide on a general standard instead of making further comparisons. Acta Paediatrica, International Journal of Paediatrics 2010 99 11 1735 1740 2-s2.0-78649735744 10.1111/j.1651-2227.2010.01911.x
27. Ascaso J. F., Pardo S., Real J. T., Lorente R. I., Priego A., Carmena R., Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003 26 12 3320 3325 2-s2.0-0344844379 10.2337/diacare.26.12.3320 (Pubitemid 37466894)
28. Borai A., Livingstone C., Kaddam I., Ferns G., Selection of the appropriate method for the assessment of insulin resistance. BMC Medical Research Methodology 2011 11, article 158 2-s2.0-81555230504 10.1186/1471-2288-11-158
29. Sabatti C., Service S. K., Hartikainen A.-L., Pouta A., Ripatti S., Brodsky J., Jones C. G., Zaitlen N. A., Varilo T., Kaakinen M., Sovio U., Ruokonen A., Laitinen J., Jakkula E., Coin L., Hoggart C., Collins A., Turunen H., Gabriel S., Elliot P., McCarthy M. I., Daly M. J., Järvelin M.-R., Freimer N. B., Peltonen L., Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nature Genetics 2009 41 1 35 46 2-s2.0-58149159573 10.1038/ng.271
30. Tanaka T., Shen J., Abecasis G. R., Kisialiou A., Ordovas J. M., Guralnik J. M., Singleton A., Bandinelli S., Cherubini A., Arnett D., Tsai M. Y., Ferrucci L., Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI study. PLoS Genetics 2009 5 1 2-s2.0-59249096217 10.1371/journal.pgen.1000338 e1000338
31. Aulchenko Y. S., Ripatti S., Lindqvist I., Loci influencing lipid levels and coronary heart disease risk in 16 european population cohorts. Nature Genetics 2009 41 1 47 55
32. Schaeffer L., Gohlke H., Müller M., Heid I. M., Palmer L. J., Kompauer I., Demmelmair H., Illig T., Koletzko B., Heinrich J., Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Human Molecular Genetics 2006 15 11 1745 1756 2-s2.0-33744736614 10.1093/hmg/ddl117 (Pubitemid 43821765)
33. Malerba G., Schaeffer L., Xumerle L., Klopp N., Trabetti E., Biscuola M., Cavallari U., Galavotti R., Martinelli N., Guarini P., Girelli D., Olivieri O., Corrocher R., Heinrich J., Pignatti P. F., Illig T., SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008 43 4 289 299 2-s2.0-46149088018 10.1007/s11745-008-3158-5
34. Kathiresan S., Willer C. J., Peloso G. M., Common variants at 30 loci contribute to polygenic dyslipidemia. Nature Genetics 2009 41 1 56 65
35. Marsh S., King C. R., Garsa A. A., McLeod H. L., Pyrosequencing of clinically relevant polymorphisms. Methods in Molecular Biology 2005 311 97 114 2-s2.0-27744583924
36. Barrett J. C., Fry B., Maller J., Daly M. J., Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 21 2 263 265 2-s2.0-13444269543 10.1093/bioinformatics/bth457 (Pubitemid 40202029)
37. Stephens M., Smith N. J., Donnelly P., A new statistical method for haplotype reconstruction from population data. The American Journal of Human Genetics 2001 68 4 978 989 2-s2.0-0035071957 10.1086/319501 (Pubitemid 32289743)
38. Stephens M., Donnelly P., A comparison of bayesian methods for haplotype reconstruction from population genotype data. The American Journal of Human Genetics 2003 73 5 1162 1169 2-s2.0-0242691208 10.1086/379378 (Pubitemid 37414228)
39. Dupuis J., Langenberg C., Prokopenko I., New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature Genetics 2010 42 2 105 116
40. Ingelsson E., Langenberg C., Hivert M.-F., Prokopenko I., Lyssenko V., Dupuis J., Mägi R., Sharp S., Jackson A. U., Assimes T. L., Shrader P., Knowles J. W., Zethelius B., Abbasi F. A., Bergman R. N., Bergmann A., Berne C., Boehnke M., Bonnycastle L. L., Bornstein S. R., Buchanan T. A., Bumpstead S. J., Böttcher Y., Chines P., Collins F. S., Cooper C. C., Dennison E. M., Erdos M. R., Ferrannini E., Fox C. S., Graessler J., Hao K., Isomaa B., Jameson K. A., Kovacs P., Kuusisto J., Laakso M., Ladenvall C., Mohlke K. L., Morken M. A., Narisu N., Nathan D. M., Pascoe L., Payne F., Petrie J. R., Sayer A. A., Schwarz P. E. H., Scott L. J., Stringham H. M., Stumvoll M., Swift A. J., Syvänen A.-C., Tuomi T., Tuomilehto J., Tönjes A., Valle T. T., Williams G. H., Lind L., Barroso I., Quertermous T., Walker M., Wareham N. J., Meigs J. B., McCarthy M. I., Groop L., Watanabe R. M., Florez J. C., Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans. Diabetes 2010 59 5 1266 1275 2-s2.0-77951858557 10.2337/db09-1568
41. Kim O. Y., Lim H. H., Yang L. I., Chae J. S., Lee J. H., Fatty acid desaturase (FADS) gene polymorphisms and insulin resistance in association with serum phospholipid polyunsaturated fatty acid composition in healthy Korean men: cross-sectional study. Nutrition and Metabolism 2011 8, article 24 2-s2.0-79955000165 10.1186/1743-7075-8-24
42. Bokor S., Dumont J., Spinneker A., Gonzalez-Gross M., Nova E., Widhalm K., Moschonis G., Stehle P., Amouyel P., De Henauw S., Molnàr D., Moreno L. A., Meirhaeghe A., Dallongeville J., Single nucleotide polymorphisms in the FADS gene cluster are associated with delta-5 and delta-6 desaturase activities estimated by serum fatty acid ratios. Journal of Lipid Research 2010 51 8 2325 2333 2-s2.0-77955425717 10.1194/jlr.M006205
43. Bays H. E., Toth P. P., Kris-Etherton P. M., Obesity, adiposity, and dyslipidemia: a consensus statement from the national lipid association. Journal of Clinical Lipidology 2013 7 4 304 383